Sanofi (TSX:SNY)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of CAD 162.45 billion. The enterprise value is 183.70 billion.

Market Cap	162.45B
Enterprise Value	183.70B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.65%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	49.94%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 10.91 and the forward PE ratio is 10.07.

PE Ratio	10.91
Forward PE	10.07
PS Ratio	2.16
PB Ratio	1.35
P/TBV Ratio	22.61
P/FCF Ratio	10.59
P/OCF Ratio	8.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.90, with an EV/FCF ratio of 11.98.

EV / Earnings	12.33
EV / Sales	2.47
EV / EBITDA	8.90
EV / EBIT	11.70
EV / FCF	11.98

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.30.

Current Ratio	1.06
Quick Ratio	0.29
Debt / Equity	0.30
Debt / EBITDA	1.72
Debt / FCF	2.32
Interest Coverage	24.55

Financial Efficiency

Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE)	8.84%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.25%
Return on Capital Employed (ROCE)	9.83%
Revenue Per Employee	905,714
Profits Per Employee	179,699
Employee Count	82,878
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sanofi has paid 2.50 billion in taxes.

Income Tax	2.50B
Effective Tax Rate	19.14%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of CAD 75.06 billion and earned 14.89 billion in profits. Earnings per share was 12.08.

Revenue	75.06B
Gross Profit	54.05B
Operating Income	15.69B
Pretax Income	13.08B
Net Income	14.89B
EBITDA	20.16B
EBIT	15.69B
Earnings Per Share (EPS)	12.08

Balance Sheet

The company has 14.55 billion in cash and 35.55 billion in debt, with a net cash position of -21.00 billion.

Cash & Cash Equivalents	14.55B
Total Debt	35.55B
Net Cash	-21.00B
Net Cash Per Share	n/a
Equity (Book Value)	120.17B
Book Value Per Share	98.29
Working Capital	3.17B

Cash Flow

In the last 12 months, operating cash flow was 18.17 billion and capital expenditures -2.83 billion, giving a free cash flow of 15.33 billion.

Operating Cash Flow	18.17B
Capital Expenditures	-2.83B
Free Cash Flow	15.33B
FCF Per Share	n/a

Margins

Gross margin is 72.00%, with operating and profit margins of 20.90% and 19.84%.

Gross Margin	72.00%
Operating Margin	20.90%
Pretax Margin	17.43%
Profit Margin	19.84%
EBITDA Margin	26.85%
EBIT Margin	20.90%
FCF Margin	20.43%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	51.62%
Buyback Yield	1.65%
Shareholder Yield	1.65%
Earnings Yield	9.17%
FCF Yield	9.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4